UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
PMN holding history
ProMIS Neurosciences Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PMN overviewAll 13F holders of PMNFull Q2 2026 holdings
- Shares (Q2 2026)
- 691
- Value
- $9.09K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 691 | $9.09K | <0.1% | −609−46.8% | Reduced | Holders |
| Q1 2026 | 1,300 | $16.5K | <0.1% | −150−10.3% | Reduced | Holders |
| Q4 2025 | 1,450 | $9.90K | <0.1% | +1,350+1,346.5% | AddedConverted for a 1-for-25 split | Holders |
| Q3 2025 | 2,506 | $1.06K | <0.1% | +2,506 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −250−100.0% | Sold out | Holders |
| Q1 2024 | 250 | $478 | <0.1% | −5,676−95.8% | Reduced | Holders |
| Q4 2023 | 5,926 | $6.82K | <0.1% | +5,823+5,653.4% | Added | Holders |
| Q3 2023 | 103 | $204 | <0.1% | −601−85.4% | Reduced | Holders |
| Q2 2023 | 704 | $2.73K | <0.1% | +704 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −2,344−100.0% | Sold out | Holders |
| Q4 2022 | 2,344 | $10.2K | <0.1% | −568−19.5% | Reduced | Holders |
| Q3 2022 | 2,912 | $18.0K | <0.1% | +2,912 | New | Holders |